TCI Wealth Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-908
Closed -$126K 400
2023
Q1
$126K Buy
908
+1
+0.1% +$135 0.02% 241
2022
Q4
$123K Buy
907
+609
+204% +$76.4K 0.02% 228
2022
Q3
$33K Buy
298
+1
+0.3% +$127 0.01% 483
2022
Q2
$39K Sell
297
-8
-3% -$1.05K 0.01% 433
2022
Q1
$40K Sell
305
-96
-24% -$11.5K 0.01% 465
2021
Q4
$47K Buy
401
+78
+24% +$9.18K 0.01% 428
2021
Q3
$39K Buy
323
+53
+20% +$6.17K 0.01% 485
2021
Q2
$32K Hold
270
0.01% 502
2021
Q1
$27K Sell
270
-305
-53% -$30.7K 0.01% 495
2020
Q4
$57K Buy
575
+481
+512% +$50.9K 0.03% 313
2020
Q3
$10K Sell
94
-96
-51% -$10.7K ﹤0.01% 577
2020
Q2
$20K Buy
+190
New +$19.6K 0.01% 443
2020
Q1
Sell
-44
Closed -$4K 1474
2019
Q4
$4K Buy
+44
New +$4.14K ﹤0.01% 894
2017
Q1
Sell
-65
Closed -$4K 1284
2016
Q4
$4K Buy
65
+45
+225% +$2.56K ﹤0.01% 805
2016
Q3
$1K Buy
+20
New +$1.31K ﹤0.01% 1082
2015
Q4
Sell
-280
Closed -$18K 1024
2015
Q3
$18K Buy
+280
New +$18.4K 0.01% 410
2013
Q3
Sell
-2,000
Closed -$95K 786
2013
Q2
$95K Buy
+2,000
New +$102K 0.07% 157

Other funds holding AZN